Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Treasury Shares (2021 - 2022)

Prokidney's (PROK) quarterly Treasury Shares came in at $25.0 million in Q2 2022, little changed quarter-over-quarter from $25.0 million in Q1 2022.

Analysis

Prokidney (PROK) Treasury Shares (2021 - 2022) Analysis & Trends

Prokidney (PROK) has reported Treasury Shares for 2 consecutive years, with $25.0 million the latest figure, recorded in Q2 2022.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $25.0 million in Q2 2022; TTM through Jun 2022 was $25.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $25.0 million, changed N/A from the prior year.
  • Treasury Shares was $25.0 million for Q2 2022 at Prokidney, roughly flat from $25.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $25.0 million in Q3 2021 and troughed at $25.0 million in Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 17.69 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn -
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn -
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 655,642.00
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -
10 Prokidney 346.07 Mn 346.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 25.00 Mn
Jun 30, 2022 25.00 Mn
Mar 31, 2022 25.00 Mn
Mar 31, 2022 25.00 Mn
Dec 31, 2021 25.00 Mn
Dec 31, 2021 25.00 Mn
Sep 30, 2021 25.00 Mn
Sep 30, 2021 25.00 Mn